Topics covered in webinar:
- Challenges in early development posed by poorly soluble APIs
- Predictive modeling and analytic techniques to drive effective and efficient technology selection
- Amorphous dispersion and lipid formulation solutions to increase bioavailability
- Advantages to addressing low solubility in early development rather than waiting to address after initial clinical results
- Case studies
|
